Sarah Howell
Directeur Général chez ARECOR THERAPEUTICS PLC
Fortune : 1 M $ au 30/04/2024
Postes actifs de Sarah Howell
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ARECOR THERAPEUTICS PLC | Directeur/Membre du Conseil | - | - |
| Directeur Général | - | - | |
| Investor Relations Contact | - | - | |
| Directeur des opérations | - | - | |
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 10/11/2011 | - |
| Directeur Général | 01/01/2015 | - | |
| Directeur des opérations | 10/11/2011 | 01/01/2015 |
Historique de carrière de Sarah Howell
Anciens postes connus de Sarah Howell
Formation de Sarah Howell
| University of St. Andrews | Doctorate Degree |
| University of Birmingham | Undergraduate Degree |
Statistiques
Internationale
| Royaume-Uni | 7 |
| Belgique | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| UCB | Health Technology |
| GSK PLC | Health Technology |
| ARECOR THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Sarah Howell
- Expérience